Topics in Breast and Gynecologic Cancers
Saturday, April 27, 2013
7:30 am – 12:30 pm
The Inn at Longwood Medical
342 Longwood Avenue
Boston, MA
Offered by Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School Department of Continuing Education.
Quicklinks
Course Overview | Agenda | Faculty
Credits | Registration Information | Course Location
Course Overview
This half-day continuing medical education course is designed for primary care physicians, gynecologists, medical oncologists, gynecologic oncologists, and other interested clinicians. Through lecture and discussion, participants will consider several breast and gynecologic topics relating to prevention and risk assessment; management of benign disease; pain management strategies; and end-of-life care, which can be applied to clinical practice. Faculty will share the latest information on the association of alcohol and breast cancer, and discuss the management of benign cervical disease including new PAP smear guidelines. They will also discuss the management of treatment side effects, pain, and end-of-life care.
Learning Objectives
At the conclusion of this course, attendees will be able to: discuss the most recent information available on alcohol and breast cancer risk; describe how and when to screen for cervical disease and manage benign cervical disease; recognize and manage side effects of cancer and treatment; summarize safe and effective pain management options that can be offered to patients; and discuss how to initiate end-of-life (EOL) planning discussions and facilitate EOL care based on patient wishes.
About the Susan F. Smith Center for Women's Cancers at Dana-Farber/ Brigham and Women's Cancer Center
The Susan F. Smith Center for Women's Cancers brings together a team of renowned experts in breast and gynecologic cancers to provide women with the most promising cancer treatments available. With an equal commitment to clinical research and care, the faculty is able to facilitate the rapid conversion of scientific discoveries into lifesaving treatments.
In addition to offering the latest treatments, the Center also provides a wide range of specialized treatment programs and other services – from support groups to complementary therapies – to help meet the diverse needs of women facing cancer.
Agenda
7:30 am
Registration Check-in and Continental Breakfast
8:00 am
Welcome and Introduction
Session I:
Breast Cancer Prevention and Management
of Benign Cervical Disease
Moderator: J. Dirk Iglehart, MD
8:10 am
Update on Alcohol, Diet, and Breast Cancer
Wendy Y. Chen, MD, MPH
8:30 am
Questions & Answers
8:40 am
Management of Benign Cervical Disease
Donald P. Goldstein, MD
9:10 am
Questions & Answers
Session II:
Treatment Update
Moderator: Ursula A. Matulonis, MD
9:20 am
Management of Side Effects of Cancer and Treatment
Douglas E. Brandoff, MD
9:50 am
Question & Answers
10:05 am
Break
10:20 am
Safe and Effective Pain Management*
Elizabeth M. Rickerson, MD
10:50 am
Questions & Answers
11:05 am
End of Life Care for Patients with Breast and Gynecologic Cancers**
Kathy J. Selvaggi, MD
11:35 am
Questions & Answers
11:50 am
Case Panel Discussion 1: Pain Management Challenges*
12:10 am
Case Panel Discussion 2: End of Life Challenges**
12:30 pm
Concluding Remarks
*Approved for a total of 1 credit of Effective Pain Management Training and 1 credit of RM Study
**Approved for a total of 1 credit of End-of-Life Care and 1 credit of RM Study
ACGME COMPETENCIES: This course is designed to enhance one or more of the following Accreditation Council of Graduate Medical Education competencies: Patient care • Medical knowledge • Practice-based learning and improvement • Interpersonal and communication skills • Professionalism • Systems-based practice.
Faculty
J. Dirk Iglehart, MD, Course Co-Director
Director, Susan F. Smith Center for Women's Cancers,
Dana-Farber/Brigham and Women's Cancer Center;
Anne E. Dyson Professor in Women's Cancer and Surgery,
Harvard Medical School
Ursula A. Matulonis, MD, Course Co-Director
Medical Director, Gynecologic Oncology, Susan F. Smith Center for Women's Cancers,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine,
Harvard Medical School
Douglas E. Brandoff, MD
Director, Adult Palliative Care Clinic,
Palliative Care Liaison to Gynecologic Oncology, Sarcoma, and Thoracic Oncology Programs,
Dana-Farber/Brigham and Women's Cancer Center;
Instructor in Medicine,
Harvard Medical School
Wendy Y. Chen, MD, MPH
Medical Oncologist, Breast Oncology, Susan F. Smith Center for Women's Cancers,
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine,
Harvard Medical School
Donald P. Goldstein, MD
Founder, New England Trophoblastic Disease Center,
Surgical Oncologist, Gynecologic Oncology,
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Obstetrics, Gynecology and Reproductive Biology,
Harvard Medical School
Elizabeth M. Rickerson, MD
Palliative Care Physician,
Dana-Farber/Brigham and Women's Cancer Center;
Instructor in Medicine,
Harvard Medical School
Kathy J. Selvaggi, MD, MS
Director, Inpatient Palliative Care Unit,
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor in Medicine,
Harvard Medical School
HMS Disclosure Policy
Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS's policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.
CME Credits
The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing education for physicians.
The Harvard Medical School designates this live activity for a maximum of 4.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Credits
This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 2.00 hours of Risk Management Study, 1.00 hour of Opioid Education and Pain Management Training, and 1.00 hour of End-of-Life Care Education. Please check with your individual state licensing board requirements before claiming Risk Management, Opioid Education and Pain Management, and End-of-Life Care training credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Registration Information
Registration Fee: $50.00 (non-refundable).
Registration fee includes: continental breakfast, course materials, and complimentary parking in the Dana-Farber garage located on Jimmy Fund Way.
To register by mail: Send a completed registration form and check made payable to DF/BWCC to:
Women's Cancers Spring 2013 CME
Dana-Farber Cancer Institute
Attn: Kamira Wooten
450 Brookline Avenue, OS 381
Boston, MA 02215
Registration form must be postmarked no later than April 19, 2013.
If you have food allergies, or if you require accommodations such as an ASL interpreter, materials in alternative format or wheelchair access, please email kwooten@partners.org or call 800-553-3787.
Course Location and Parking Information
This course is being held at The Inn at Longwood Medical, located at 342 Longwood Avenue. Complimentary parking is available for attendees only in the Dana-Farber garage, located on Jimmy Fund Way (cross street: 450 Brookline Ave. For direction, please visit: www.dana-farber.org/directions. The Inn at Longwood Medical is one block from the garage and within short walking distance.
